Literature DB >> 26928933

Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.

Johnnie K Bass1, Kristin R Knight2, Torunn I Yock3, Kay W Chang4, Douglas Cipkala5, Satkiran S Grewal6.   

Abstract

Hearing loss (HL) is common in childhood cancer survivors exposed to platinum chemotherapy and/or cranial radiation and can severely impact quality of life. Early detection and appropriate management can mitigate academic, speech, language, social, and psychological morbidity resulting from hearing deficits. This review is targeted as a resource for providers involved in aftercare of childhood cancers. The goal is to promote early identification of survivors at-risk for HL, appropriate evaluation and interpretation of diagnostic tests, timely referral to an audiologist when indicated, and to increase knowledge of current therapeutic options.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer survivor; hearing loss; late effects; ototoxicity

Mesh:

Year:  2016        PMID: 26928933      PMCID: PMC5520626          DOI: 10.1002/pbc.25951

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  49 in total

Review 1.  Assessment of hearing in very young children receiving carboplatin for retinoblastoma.

Authors:  Cas Smits; Suzanne J Swen; S Theo Goverts; Annette C Moll; Saskia M Imhof; Antoinette Y N Schouten-van Meeteren
Journal:  Eur J Cancer       Date:  2006-01-11       Impact factor: 9.162

2.  Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aids.

Authors:  Einar-Jón Einarsson; Hannes Petersen; Thomas Wiebe; Per-Anders Fransson; Måns Magnusson; Christian Moëll
Journal:  Int J Audiol       Date:  2011-08-03       Impact factor: 2.117

3.  Cisplatin-induced hearing loss: the need for a long-term evaluating system.

Authors:  Naoko Yasui; Nodoka Adachi; Motohiro Kato; Katsuyoshi Koh; Satoshi Asanuma; Hideaki Sakata; Ryoji Hanada
Journal:  J Pediatr Hematol Oncol       Date:  2014-05       Impact factor: 1.289

4.  Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status.

Authors:  F H Bess; J Dodd-Murphy; R A Parker
Journal:  Ear Hear       Date:  1998-10       Impact factor: 3.570

5.  Language of early- and later-identified children with hearing loss.

Authors:  C Yoshinaga-Itano; A L Sedey; D K Coulter; A L Mehl
Journal:  Pediatrics       Date:  1998-11       Impact factor: 7.124

6.  Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.

Authors:  Tara M Brinkman; Johnnie K Bass; Zhenghong Li; Kirsten K Ness; Amar Gajjar; Alberto S Pappo; Gregory T Armstrong; Thomas E Merchant; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; James G Gurney
Journal:  Cancer       Date:  2015-08-19       Impact factor: 6.860

Review 7.  The importance of high-frequency audibility in the speech and language development of children with hearing loss.

Authors:  Patricia G Stelmachowicz; Andrea L Pittman; Brenda M Hoover; Dawna E Lewis; Mary Pat Moeller
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-05

8.  Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors.

Authors:  Thomas E Merchant; Ciara J Gould; Xiaoping Xiong; Nicole Robbins; Junhong Zhu; David L Pritchard; Raja Khan; Richard L Heideman; Matthew J Krasin; Larry E Kun
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-15       Impact factor: 7.038

9.  Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.

Authors:  S K Parsons; M W Neault; L E Lehmann; L L Brennan; C E Eickhoff; C S Kretschmar; L R Diller
Journal:  Bone Marrow Transplant       Date:  1998-10       Impact factor: 5.483

10.  Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.

Authors:  Benjamin J Moeller; Murali Chintagumpala; Jimmy J Philip; David R Grosshans; Mary F McAleer; Shiao Y Woo; Paul W Gidley; Tribhawan S Vats; Anita Mahajan
Journal:  Radiat Oncol       Date:  2011-06-02       Impact factor: 3.481

View more
  7 in total

1.  Prevalence of Ototoxicity Following Hematopoietic Stem Cell Transplantation in Pediatric Patients.

Authors:  Kristen Gertson; Susan S Hayashi; Kathryn Trinkaus; Fei Wan; Robert J Hayashi
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-05       Impact factor: 5.742

2.  Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.

Authors:  Shirin Ardeshirrouhanifard; Sophie D Fossa; Robert Huddart; Patrick O Monahan; Chunkit Fung; Yiqing Song; M Eileen Dolan; Darren R Feldman; Robert J Hamilton; David Vaughn; Neil E Martin; Christian Kollmannsberger; Paul Dinh; Lawrence Einhorn; Robert D Frisina; Lois B Travis
Journal:  Ear Hear       Date:  2022 May/Jun       Impact factor: 3.562

3.  Hearing Loss in Adult Survivors of Childhood Cancer Treated with Radiotherapy.

Authors:  Amber Khan; Amy Budnick; Dana Barnea; Darren R Feldman; Kevin C Oeffinger; Emily S Tonorezos
Journal:  Children (Basel)       Date:  2018-05-04

Review 4.  Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer.

Authors:  Alberto Romano; Michele Antonio Capozza; Stefano Mastrangelo; Palma Maurizi; Silvia Triarico; Rolando Rolesi; Giorgio Attinà; Anna Rita Fetoni; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2020-05-17       Impact factor: 6.639

5.  Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.

Authors:  Iska Moxon-Emre; Christine Dahl; Vijay Ramaswamy; Ute Bartels; Uri Tabori; Annie Huang; Sharon L Cushing; Vicky Papaioannou; Normand Laperriere; Eric Bouffet; Donald J Mabbott
Journal:  Cancer Med       Date:  2021-09-04       Impact factor: 4.452

6.  Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.

Authors:  Sally Cohen-Cutler; Kenneth Wong; Victoria Mena; Kevin Sianto; Michael A Wright; Arthur Olch; Etan Orgel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-03-04       Impact factor: 8.013

Review 7.  Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine.

Authors:  Hedy Maagdenberg; Susanne J H Vijverberg; Marc B Bierings; Bruce C Carleton; Hubertus G M Arets; Anthonius de Boer; Anke H Maitland-van der Zee
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.